Abstract
The genes MBD1 and MBD2 encode methyl-CpG binding proteins that suppress transcription from methylated promoters. In contrast, CGBP encodes a protein that binds promoters containing unmethylated CpG and stimulates transcription. All three are located on human chromosome 18q21, a region of frequent loss of heterozygosity in several cancers. These genes therefore represent candidate tumour suppressor genes, whose loss of function could affect the normal regulation of gene expression, whether by lack of complete suppression of genes normally silenced (via loss of MBD1 and MBD2) or by some loss of activation of genes normally expressed (via loss of CGBP), either way contributing to the tumorigenic phenotype. We have confirmed by fluorescent in situ hybridization that MBD1 and MBD2 bracket the DCC locus giving a gene order of MBD1/CGBP-DCC 5'-DCC 3'-MBD2. Mutation analyses by single-stranded conformation polymorphism in colon and lung cancer cell lines and primary tumours revealed a small number of mutations, suggesting only a limited role of these genes in human tumorigenesis.
Original language | English |
---|---|
Pages (from-to) | 3506-3510 |
Number of pages | 5 |
Journal | Oncogene |
Volume | 22 |
Issue number | 22 |
DOIs | |
Publication status | Published - 29 May 2003 |
Keywords
- Chromosomes, Human, Pair 18
- Colonic neoplasms
- CpG islands
- DNA methylation
- DNA-binding proteins
- Gene expression regulation, Neoplastic
- Gene silencing
- Humans
- In Situ hybridization, fluorescence
- Lung neoplasms
- Mutation
- Repressor proteins
- Transcription factors